4//SEC Filing
Mikhak Zamaneh 4
Accession 0001213900-23-019383
CIK 0001733413other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:00 AM ET
Size
5.0 KB
Accession
0001213900-23-019383
Insider Transaction Report
Form 4
Mikhak Zamaneh
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-03-10$0.82/sh+15,000$12,300→ 15,000 total
Footnotes (1)
- [F1]The reported shares were purchased in the open market in multiple transactions at prices ranging from $0.8099 to $.8200. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001962453
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 8:00 AM ET
- Size
- 5.0 KB